• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的患病率及危险因素:狄俄尼索斯营养与肝脏研究

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

作者信息

Bedogni Giorgio, Miglioli Lucia, Masutti Flora, Tiribelli Claudio, Marchesini Giulio, Bellentani Stefano

机构信息

Centro Studi Fegato, AREA Science Park, Basovizza, and Department of BBCM, University of Trieste, Italy.

出版信息

Hepatology. 2005 Jul;42(1):44-52. doi: 10.1002/hep.20734.

DOI:10.1002/hep.20734
PMID:15895401
Abstract

The prevalence of and the risk factors for fatty liver have not undergone a formal evaluation in a representative sample of the general population. We therefore performed a cross-sectional study in the town of Campogalliano (Modena, Italy), within the context of the Dionysos Project. Of 5,780 eligible persons aged 18 to 75 years, 3,345 (58%) agreed to participate in the study. Subjects with suspected liver disease (SLD), defined on the basis of elevated serum alanine aminotransferase (ALT) and gamma-glutamyl-transferase (GGT) activity, hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV)-RNA positivity, were matched with randomly selected subjects of the same age and sex without SLD. A total of 311 subjects with and 287 without SLD underwent a detailed clinical, laboratory, and anthropometrical evaluation. Fatty liver was diagnosed by ultrasonography, and alcohol intake was assessed by using a 7-day diary. Multinomial logistic regression was used to detect risk factors for normal liver versus nonalcoholic fatty liver disease (NAFLD) and for alcoholic fatty liver (AFLD) versus NAFLD. The prevalence of NAFLD was similar in subjects with and without SLD (25 vs. 20%, P = .203). At multivariable analysis, normal liver was more likely than NAFLD in older subjects and less likely in the presence of obesity, hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and systolic hypertension; AFLD was more likely than NAFLD in older subjects, males, and in the presence of elevated GGT and hypertriglyceridemia, and less likely in the presence of obesity and hyperglycemia. In conclusion, NAFLD is highly prevalent in the general population, is not associated with SLD, but is associated with many features of the metabolic syndrome.

摘要

在普通人群的代表性样本中,尚未对脂肪肝的患病率及其危险因素进行正式评估。因此,我们在意大利摩德纳市坎波加利亚诺镇开展了一项横断面研究,该研究是酒神计划的一部分。在5780名年龄在18至75岁的符合条件者中,3345人(58%)同意参与研究。根据血清丙氨酸氨基转移酶(ALT)和γ-谷氨酰转移酶(GGT)活性升高、乙肝表面抗原(HBsAg)或丙型肝炎病毒(HCV)-RNA阳性定义的疑似肝病(SLD)患者,与随机选择的同年龄、同性别的无SLD患者进行匹配。共有311名有SLD的患者和287名无SLD的患者接受了详细的临床、实验室和人体测量学评估。通过超声诊断脂肪肝,通过7天日记评估酒精摄入量。采用多项逻辑回归分析来检测正常肝脏与非酒精性脂肪性肝病(NAFLD)以及酒精性脂肪性肝病(AFLD)与NAFLD的危险因素。有SLD和无SLD的患者中NAFLD的患病率相似(分别为25%和20%,P = 0.203)。在多变量分析中,老年受试者中正常肝脏比NAFLD更常见,而在存在肥胖、高血糖、高胰岛素血症、高甘油三酯血症和收缩期高血压的情况下则较少见;老年受试者、男性以及存在GGT升高和高甘油三酯血症时,AFLD比NAFLD更常见,而在存在肥胖和高血糖时则较少见。总之,NAFLD在普通人群中非常普遍,与SLD无关,但与代谢综合征的许多特征相关。

相似文献

1
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.非酒精性脂肪性肝病的患病率及危险因素:狄俄尼索斯营养与肝脏研究
Hepatology. 2005 Jul;42(1):44-52. doi: 10.1002/hep.20734.
2
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.丙型肝炎患者的非酒精性脂肪性肝病与代谢综合征的特征相关。
Am J Gastroenterol. 2003 Sep;98(9):2064-71. doi: 10.1111/j.1572-0241.2003.07640.x.
3
Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.斯里兰卡城市成年人群中非酒精性脂肪性肝病的患病率及危险因素
J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. Epub 2009 May 19.
4
Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.一项基于人群的研究中,原发性非酒精性脂肪性肝病的患病率及其与生化和人体测量指标的关联。
Liver Int. 2006 Sep;26(7):856-63. doi: 10.1111/j.1478-3231.2006.01311.x.
5
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.非酒精性脂肪性肝病作为糖尿病和代谢综合征发生的危险因素:一项为期11年的随访研究。
Am J Gastroenterol. 2009 Apr;104(4):861-7. doi: 10.1038/ajg.2009.67. Epub 2009 Mar 17.
6
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.转诊至代谢门诊的HIV感染患者中的非酒精性脂肪性肝病:患病率、特征及预测因素
Clin Infect Dis. 2008 Jul 15;47(2):250-7. doi: 10.1086/589294.
7
Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.台湾成年人群血清丙氨酸氨基转移酶水平升高的患病率及病因
J Gastroenterol Hepatol. 2007 Sep;22(9):1482-9. doi: 10.1111/j.1440-1746.2006.04615.x.
8
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.非肥胖、非糖尿病成年人非酒精性脂肪性肝病的代谢意义
Arch Intern Med. 2004 Oct 25;164(19):2169-75. doi: 10.1001/archinte.164.19.2169.
9
Epidemiology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的流行病学。
Dig Dis. 2010;28(1):155-61. doi: 10.1159/000282080. Epub 2010 May 7.
10
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?亚太地区非酒精性脂肪性肝病的风险因素及相关情况有哪些?
J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13.

引用本文的文献

1
Hyperuricemia in Chinese Patients with Mood Disorders: Prevalence, Related Factors, and Predictive Model.中国心境障碍患者的高尿酸血症:患病率、相关因素及预测模型
Neuropsychiatr Dis Treat. 2025 Aug 31;21:1885-1897. doi: 10.2147/NDT.S535310. eCollection 2025.
2
Prevalence and associated factors with non-alcoholic fatty liver disease in a group of obese women in Tunisia.突尼斯一组肥胖女性中非酒精性脂肪性肝病的患病率及相关因素
Pan Afr Med J. 2025 May 2;51:1. doi: 10.11604/pamj.2025.51.1.46987. eCollection 2025.
3
Combined impact of prediabetes and fatty liver index on cardiometabolic outcomes and mortality in middle aged adults: a nationwide cohort study.
中年成年人中糖尿病前期与脂肪肝指数对心脏代谢结局和死亡率的联合影响:一项全国性队列研究
Cardiovasc Diabetol. 2025 Jul 10;24(1):279. doi: 10.1186/s12933-025-02793-7.
4
Association between lifestyle factors and liver function parameters in the middle-aged and older population.中年及老年人群生活方式因素与肝功能参数之间的关联
BMC Public Health. 2025 May 26;25(1):1947. doi: 10.1186/s12889-025-22260-y.
5
Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?用于识别肥胖青少年代谢功能障碍相关脂肪性肝病(MASLD)的内脏脂肪、人体测量指标和肝功能指标:哪种表现更佳?
J Clin Med. 2025 Mar 19;14(6):2085. doi: 10.3390/jcm14062085.
6
Investigation of calonysterone and 20-hydroxyecdysone effects in high-fat, high-sugar diet-induced obesity rat model.卡洛芬甾酮和20-羟基蜕皮酮对高脂高糖饮食诱导的肥胖大鼠模型影响的研究。
Heliyon. 2025 Feb 4;11(3):e42435. doi: 10.1016/j.heliyon.2025.e42435. eCollection 2025 Feb 15.
7
Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis.补充鱼油对代谢功能障碍相关脂肪性肝病的疗效:一项荟萃分析。
Front Nutr. 2025 Jan 24;12:1524830. doi: 10.3389/fnut.2025.1524830. eCollection 2025.
8
Liver biopsy in patients with gall stone disease and concomitant non-alcoholic fatty liver disease undergoing cholecystectomy: A prospective observational study.胆囊结石病合并非酒精性脂肪性肝病患者行胆囊切除术时的肝活检:一项前瞻性观察研究。
Turk J Surg. 2024 Sep 30;40(3):190-196. doi: 10.47717/turkjsurg.2024.6488. eCollection 2024 Sep.
9
Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.204 个国家和地区 1990 年至 2021 年归因于空腹血糖升高的代谢功能障碍相关脂肪性肝病的全球负担。
Sci Rep. 2024 Sep 27;14(1):22232. doi: 10.1038/s41598-024-72795-0.
10
Assessment of the Liver Steatosis and Fibrosis Risk in Metabolic Syndrome and Its Individual Components, Considering the Varying Definitions Used in Clinical Practice throughout Time: A Retrospective Cross-Sectional Study.考虑到临床实践中随时间变化使用的不同定义,对代谢综合征及其各个组成部分的肝脏脂肪变性和纤维化风险进行评估:一项回顾性横断面研究。
Biomedicines. 2024 Aug 2;12(8):1739. doi: 10.3390/biomedicines12081739.